search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MEDICAL GASES


Table 1. Chemical elements in the USP formula and postulate impacts of a breach condition. USP element (breach condition)


Impact considerations Oxygen content high (>23.5% v/v) Oxygen content low (<19.5% v/v) Carbon monoxide (>10 ppm)


Measured incidents of high oxygen content are thus far limited to <30% v/v and duration is typically less than five minutes. It is generally assumed that short term high oxygen release will homogenise through pipeline travel


Short term oxygen deprivation can have serious health effects in ventilated patients, especially neonates. Most anoxia monitors are set to alarm at 18% v/v, and there are cases on record of site produced medical air with O2


levels below this threshold


Sustained exposure to CO levels as low as 30 ppm can have serious long term health effects. Exposure to high levels of CO (ie >100 ppm) can be fatal. Haemoglobin is –240 times more attracted to CO than oxygen, so ensuring CO levels below the USP limit of 10 ppm is of paramount importance


Carbon dioxide (>500 ppm)


Elevated CO2 levels increase risk of respiratory failure or hyperventilation. The level at which CO2


Sites providing neonatal care may have greater concerns over CO2 the potential for a CO2


bolus release Humidity (> 5˚C pressure dewpoint* NOx (NO + NO2 >2.5 ppm)


Sulphur dioxide (>5 ppm) Oil (none detectable)


With strong evidence that a quality breach is expected, the consequences must be assessed. There are numerous studies confirming the health effects of common air pollutants, but none evaluate the effects on respiratory patients inhaling contaminated medical air. So we must start in a general sense by looking at the chemical elements in the USP formula and postulate impacts of a breach condition (see Table 1). Since medical air is a common adjunct


to respiratory therapies, it is recommended that the question set is expanded to include a few site specific queries: l Are the therapies involving medical air at this site typically of long (more than two hours) or short (less than two hours) duration?


l Do the medical devices typically involved monitor the USP chemical elements in the medical air prior to


Where potential for harmful exposure is low, the frequency of monitoring and method of off-spec prevention should be site determined IFHE DIGEST 2018


) bolus to cause short term oxygen deprivation as the bolus


exits the pipeline through a terminal unit. All desiccant air dryers are prone to sudden CO2


Humidity in the pipeline promotes bacterial growth and may harm sensitive medical devices. While moisture in medical air pipelines and related device damage is well documented, more research on pipeline bio-burden is necessary


Both NO and NO2 are respiratory irritants, and in volumes exceeding the USP limit


can lead to serious health problems or death A recognised toxic gas with serious health effects


Not considered given CSA restrictions on use of oil flooded compressor technologies *CSA Z7396.1 prescribed dewpoint, which exceeds USP requirements


patient inhalation and alarm in the event of an off-spec condition?


l Will the patient typically be able to voice concern if they sense a problem during treatment (for example, a strange smell)?


Answers can be used to formulate a site specific ‘potential for harmful exposure’.


1000 900 800 700 600 500 400 300 200 100 0


Table 2 assesses the most common therapies involving medical air.


Quality risk assessment Considering the information provided, it is necessary to return to the purpose of the quality risk assessment, which is to determine the frequency of sampling and analysis and the operating methods


becomes a concern seems dependent on patient type and co-morbidities. incursions given


n CO2


USP Limit


18 October 2016 (1,440 minutes)


Figure 1. A full day (one data point per minute) of CO2 The sine wave indicates the catch and release of CO2 depicts a quality breach whereby the measured CO2


measured in medical air. by a desiccant dryer and eclipses the pharmacopoeia


limit of 500 ppm. The severe peak suggests a bolus release, which presents a serious patient safety hazard.


85


PPM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88